Listed

Angiodynamics Inc

ANGONasdaqCIK 1275187HealthcareFiscal year ends May 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$80.9m, Q1 FY2027
Operating income−$7.3m, Q1 FY2027
Net income−$7.1m, Q1 FY2027
Angiodynamics Inc, income statement, quarterly
Line itemUnitQ2 FY20242023-11-30Q3 FY20242024-02-29Q4 FY20242024-05-31Q1 FY20252024-08-31Q2 FY20252024-11-30Q3 FY20252025-02-28Q4 FY20252025-05-31Q1 FY20262025-08-31Q2 FY20262025-11-30Q3 FY20262026-02-28Q4 FY20262026-05-31Q1 FY20272026-08-31
Revenue$m79.1Revenue, Q2 FY2024, three months to 2023-11-30$79.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-01-08, accession 0001275187-25-000005.Report this figure75.2Revenue, Q3 FY2024, three months to 2024-02-29$75.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-04-02, accession 0001275187-25-000010.Report this figure71.0Revenue, Q4 FY2024, three months to 2024-05-31$71.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-07-14, accession 0001628280-26-048138. Derived: 12-month figure less the 9-month figure.Report this figure67.5Revenue, Q1 FY2025, three months to 2024-08-31$67.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-10-02, accession 0001628280-25-043689.Report this figure72.8Revenue, Q2 FY2025, three months to 2024-11-30$72.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-01-06, accession 0001275187-26-000003.Report this figure72.0Revenue, Q3 FY2025, three months to 2025-02-28$72.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-04-02, accession 0001628280-26-023008.Report this figure80.2Revenue, Q4 FY2025, three months to 2025-05-31$80.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-07-14, accession 0001628280-26-048138. Derived: 12-month figure less the 9-month figure.Report this figure75.7Revenue, Q1 FY2026, three months to 2025-08-31$75.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-10-08, accession 0001628280-26-065423.Report this figure79.4Revenue, Q2 FY2026, three months to 2025-11-30$79.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-01-06, accession 0001275187-26-000003.Report this figure78.4Revenue, Q3 FY2026, three months to 2026-02-28$78.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-04-02, accession 0001628280-26-023008.Report this figure86.6Revenue, Q4 FY2026, three months to 2026-05-31$86.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-07-14, accession 0001628280-26-048138. Derived: 12-month figure less the 9-month figure.Report this figure80.9Revenue, Q1 FY2027, three months to 2026-08-31$80.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-10-08, accession 0001628280-26-065423.Report this figure
Cost of revenue$m38.8Cost of revenue, Q2 FY2024, three months to 2023-11-30$38.8m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-01-08, accession 0001275187-25-000005.Report this figure39.3Cost of revenue, Q3 FY2024, three months to 2024-02-29$39.3m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-04-02, accession 0001275187-25-000010.Report this figure32.5Cost of revenue, Q4 FY2024, three months to 2024-05-31$32.5m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2026-07-14, accession 0001628280-26-048138. Derived: 12-month figure less the 9-month figure.Report this figure30.8Cost of revenue, Q1 FY2025, three months to 2024-08-31$30.8m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-10-02, accession 0001628280-25-043689.Report this figure32.9Cost of revenue, Q2 FY2025, three months to 2024-11-30$32.9m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-01-06, accession 0001275187-26-000003.Report this figure33.1Cost of revenue, Q3 FY2025, three months to 2025-02-28$33.1m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-04-02, accession 0001628280-26-023008.Report this figure37.9Cost of revenue, Q4 FY2025, three months to 2025-05-31$37.9m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2026-07-14, accession 0001628280-26-048138. Derived: 12-month figure less the 9-month figure.Report this figure33.9Cost of revenue, Q1 FY2026, three months to 2025-08-31$33.9m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-10-08, accession 0001628280-26-065423.Report this figure34.7Cost of revenue, Q2 FY2026, three months to 2025-11-30$34.6m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-01-06, accession 0001275187-26-000003.Report this figure36.9Cost of revenue, Q3 FY2026, three months to 2026-02-28$36.9m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-04-02, accession 0001628280-26-023008.Report this figure39.8Cost of revenue, Q4 FY2026, three months to 2026-05-31$39.8m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2026-07-14, accession 0001628280-26-048138. Derived: 12-month figure less the 9-month figure.Report this figure32.9Cost of revenue, Q1 FY2027, three months to 2026-08-31$32.9m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-10-08, accession 0001628280-26-065423.Report this figure
Gross profit$m40.3Gross profit, Q2 FY2024, three months to 2023-11-30$40.3m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-01-08, accession 0001275187-25-000005.Report this figure35.9Gross profit, Q3 FY2024, three months to 2024-02-29$35.9m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-04-02, accession 0001275187-25-000010.Report this figure38.5Gross profit, Q4 FY2024, three months to 2024-05-31$38.5m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-07-14, accession 0001628280-26-048138. Derived: 12-month figure less the 9-month figure.Report this figure36.7Gross profit, Q1 FY2025, three months to 2024-08-31$36.7m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-10-02, accession 0001628280-25-043689.Report this figure39.9Gross profit, Q2 FY2025, three months to 2024-11-30$39.9m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-01-06, accession 0001275187-26-000003.Report this figure38.9Gross profit, Q3 FY2025, three months to 2025-02-28$38.9m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-04-02, accession 0001628280-26-023008.Report this figure42.2Gross profit, Q4 FY2025, three months to 2025-05-31$42.2m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-07-14, accession 0001628280-26-048138. Derived: 12-month figure less the 9-month figure.Report this figure41.9Gross profit, Q1 FY2026, three months to 2025-08-31$41.9m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-10-08, accession 0001628280-26-065423.Report this figure44.8Gross profit, Q2 FY2026, three months to 2025-11-30$44.8m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-01-06, accession 0001275187-26-000003.Report this figure41.5Gross profit, Q3 FY2026, three months to 2026-02-28$41.5m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-04-02, accession 0001628280-26-023008.Report this figure46.8Gross profit, Q4 FY2026, three months to 2026-05-31$46.8m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-07-14, accession 0001628280-26-048138. Derived: 12-month figure less the 9-month figure.Report this figure48.0Gross profit, Q1 FY2027, three months to 2026-08-31$48.0m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-10-08, accession 0001628280-26-065423.Report this figure
Research and development$m8.7Research and development, Q2 FY2024, three months to 2023-11-30$8.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-01-08, accession 0001275187-25-000005.Report this figure8.2Research and development, Q3 FY2024, three months to 2024-02-29$8.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-04-02, accession 0001275187-25-000010.Report this figure6.7Research and development, Q4 FY2024, three months to 2024-05-31$6.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-07-14, accession 0001628280-26-048138. Derived: 12-month figure less the 9-month figure.Report this figure6.3Research and development, Q1 FY2025, three months to 2024-08-31$6.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-10-02, accession 0001628280-25-043689.Report this figure6.4Research and development, Q2 FY2025, three months to 2024-11-30$6.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-01-06, accession 0001275187-26-000003.Report this figure6.9Research and development, Q3 FY2025, three months to 2025-02-28$6.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-04-02, accession 0001628280-26-023008.Report this figure6.6Research and development, Q4 FY2025, three months to 2025-05-31$6.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-07-14, accession 0001628280-26-048138. Derived: 12-month figure less the 9-month figure.Report this figure6.4Research and development, Q1 FY2026, three months to 2025-08-31$6.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-10-08, accession 0001628280-26-065423.Report this figure7.8Research and development, Q2 FY2026, three months to 2025-11-30$7.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-01-06, accession 0001275187-26-000003.Report this figure7.1Research and development, Q3 FY2026, three months to 2026-02-28$7.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-04-02, accession 0001628280-26-023008.Report this figure8.2Research and development, Q4 FY2026, three months to 2026-05-31$8.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-07-14, accession 0001628280-26-048138. Derived: 12-month figure less the 9-month figure.Report this figure8.0Research and development, Q1 FY2027, three months to 2026-08-31$8.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-10-08, accession 0001628280-26-065423.Report this figure
Operating income$m(13.1)Operating income, Q2 FY2024, three months to 2023-11-30−$13.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-01-08, accession 0001275187-25-000005.Report this figure(200)Operating income, Q3 FY2024, three months to 2024-02-29−$199.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-04-02, accession 0001275187-25-000010.Report this figure(14.4)Operating income, Q4 FY2024, three months to 2024-05-31−$14.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-07-14, accession 0001628280-26-048138. Derived: 12-month figure less the 9-month figure.Report this figure(13.1)Operating income, Q1 FY2025, three months to 2024-08-31−$13.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-10-02, accession 0001628280-25-043689.Report this figure(11.1)Operating income, Q2 FY2025, three months to 2024-11-30−$11.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-01-06, accession 0001275187-26-000003.Report this figure(10.0)Operating income, Q3 FY2025, three months to 2025-02-28−$10.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-04-02, accession 0001628280-26-023008.Report this figure(5.8)Operating income, Q4 FY2025, three months to 2025-05-31−$5.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-07-14, accession 0001628280-26-048138. Derived: 12-month figure less the 9-month figure.Report this figure(10.7)Operating income, Q1 FY2026, three months to 2025-08-31−$10.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-10-08, accession 0001628280-26-065423.Report this figure(6.1)Operating income, Q2 FY2026, three months to 2025-11-30−$6.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-01-06, accession 0001275187-26-000003.Report this figure(13.0)Operating income, Q3 FY2026, three months to 2026-02-28−$13.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-04-02, accession 0001628280-26-023008.Report this figure(10.2)Operating income, Q4 FY2026, three months to 2026-05-31−$10.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-07-14, accession 0001628280-26-048138. Derived: 12-month figure less the 9-month figure.Report this figure(7.3)Operating income, Q1 FY2027, three months to 2026-08-31−$7.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-10-08, accession 0001628280-26-065423.Report this figure
Interest expense$m(0.5)Interest expense, Q2 FY2024, three months to 2023-11-30−$534.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2024-01-08, accession 0001628280-24-000857.Report this figure(0.4)Interest expense, Q3 FY2024, three months to 2024-02-29−$394.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2024-04-09, accession 0001628280-24-015487.Report this figure(0.6)Interest expense, Q4 FY2024, three months to 2024-05-31−$567.0k. XBRL concept us-gaap:InterestExpense. 10-K filed 2024-07-25, accession 0001628280-24-032989. Derived: 12-month figure less the 9-month figure.Report this figurenot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Income tax$m16.4Income tax, Q2 FY2024, three months to 2023-11-30$16.4m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-01-08, accession 0001275187-25-000005.Report this figure(12.0)Income tax, Q3 FY2024, three months to 2024-02-29−$12.0m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-04-02, accession 0001275187-25-000010.Report this figure(0.7)Income tax, Q4 FY2024, three months to 2024-05-31−$692.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-07-14, accession 0001628280-26-048138. Derived: 12-month figure less the 9-month figure.Report this figure0.1Income tax, Q1 FY2025, three months to 2024-08-31$133.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-10-02, accession 0001628280-25-043689.Report this figure(0.1)Income tax, Q2 FY2025, three months to 2024-11-30−$110.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-01-06, accession 0001275187-26-000003.Report this figure(0.0)Income tax, Q3 FY2025, three months to 2025-02-28−$2.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-04-02, accession 0001628280-26-023008.Report this figure(0.1)Income tax, Q4 FY2025, three months to 2025-05-31−$60.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-07-14, accession 0001628280-26-048138. Derived: 12-month figure less the 9-month figure.Report this figure0.1Income tax, Q1 FY2026, three months to 2025-08-31$65.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-10-08, accession 0001628280-26-065423.Report this figure(0.0)Income tax, Q2 FY2026, three months to 2025-11-30−$5.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-01-06, accession 0001275187-26-000003.Report this figure0.0Income tax, Q3 FY2026, three months to 2026-02-28$12.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-04-02, accession 0001628280-26-023008.Report this figure0.4Income tax, Q4 FY2026, three months to 2026-05-31$370.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-07-14, accession 0001628280-26-048138. Derived: 12-month figure less the 9-month figure.Report this figure(0.2)Income tax, Q1 FY2027, three months to 2026-08-31−$199.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-10-08, accession 0001628280-26-065423.Report this figure
Net income$m(29.0)Net income, Q2 FY2024, three months to 2023-11-30−$29.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-04-02, accession 0001275187-25-000010.Report this figure(188)Net income, Q3 FY2024, three months to 2024-02-29−$187.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-04-02, accession 0001275187-25-000010.Report this figure(13.5)Net income, Q4 FY2024, three months to 2024-05-31−$13.4m. XBRL concept us-gaap:NetIncomeLoss. 10-K/A filed 2026-09-29, accession 0001140361-26-037995. Derived: 12-month figure less the 9-month figure.Report this figure(12.8)Net income, Q1 FY2025, three months to 2024-08-31−$12.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-04-02, accession 0001628280-26-023008.Report this figure(10.7)Net income, Q2 FY2025, three months to 2024-11-30−$10.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-04-02, accession 0001628280-26-023008.Report this figure(4.4)Net income, Q3 FY2025, three months to 2025-02-28−$4.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-04-02, accession 0001628280-26-023008.Report this figure(6.1)Net income, Q4 FY2025, three months to 2025-05-31−$6.0m. XBRL concept us-gaap:NetIncomeLoss. 10-K/A filed 2026-09-29, accession 0001140361-26-037995. Derived: 12-month figure less the 9-month figure.Report this figure(10.9)Net income, Q1 FY2026, three months to 2025-08-31−$10.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-10-08, accession 0001628280-26-065423.Report this figure(6.4)Net income, Q2 FY2026, three months to 2025-11-30−$6.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-04-02, accession 0001628280-26-023008.Report this figure(8.1)Net income, Q3 FY2026, three months to 2026-02-28−$8.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-04-02, accession 0001628280-26-023008.Report this figure(11.4)Net income, Q4 FY2026, three months to 2026-05-31−$11.4m. XBRL concept us-gaap:NetIncomeLoss. 10-K/A filed 2026-09-29, accession 0001140361-26-037995. Derived: 12-month figure less the 9-month figure.Report this figure(7.1)Net income, Q1 FY2027, three months to 2026-08-31−$7.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-10-08, accession 0001628280-26-065423.Report this figure
Diluted EPS$ per share(0.72)Diluted EPS, Q2 FY2024, three months to 2023-11-30−$0.72 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-01-08, accession 0001275187-25-000005.Report this figure(4.67)Diluted EPS, Q3 FY2024, three months to 2024-02-29−$4.67 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-04-02, accession 0001275187-25-000010.Report this figurenot reported(0.31)Diluted EPS, Q1 FY2025, three months to 2024-08-31−$0.31 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-10-02, accession 0001628280-25-043689.Report this figure(0.26)Diluted EPS, Q2 FY2025, three months to 2024-11-30−$0.26 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-01-06, accession 0001275187-26-000003.Report this figure(0.11)Diluted EPS, Q3 FY2025, three months to 2025-02-28−$0.11 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-04-02, accession 0001628280-26-023008.Report this figurenot reported(0.26)Diluted EPS, Q1 FY2026, three months to 2025-08-31−$0.26 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-10-08, accession 0001628280-26-065423.Report this figure(0.15)Diluted EPS, Q2 FY2026, three months to 2025-11-30−$0.15 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-01-06, accession 0001275187-26-000003.Report this figure(0.19)Diluted EPS, Q3 FY2026, three months to 2026-02-28−$0.19 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-04-02, accession 0001628280-26-023008.Report this figurenot reported(0.17)Diluted EPS, Q1 FY2027, three months to 2026-08-31−$0.17 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-10-08, accession 0001628280-26-065423.Report this figure
Basic EPS$ per share(0.72)Basic EPS, Q2 FY2024, three months to 2023-11-30−$0.72 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-01-08, accession 0001275187-25-000005.Report this figure(4.67)Basic EPS, Q3 FY2024, three months to 2024-02-29−$4.67 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-04-02, accession 0001275187-25-000010.Report this figurenot reported(0.31)Basic EPS, Q1 FY2025, three months to 2024-08-31−$0.31 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-10-02, accession 0001628280-25-043689.Report this figure(0.26)Basic EPS, Q2 FY2025, three months to 2024-11-30−$0.26 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-01-06, accession 0001275187-26-000003.Report this figure(0.11)Basic EPS, Q3 FY2025, three months to 2025-02-28−$0.11 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-04-02, accession 0001628280-26-023008.Report this figurenot reported(0.26)Basic EPS, Q1 FY2026, three months to 2025-08-31−$0.26 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-10-08, accession 0001628280-26-065423.Report this figure(0.15)Basic EPS, Q2 FY2026, three months to 2025-11-30−$0.15 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-01-06, accession 0001275187-26-000003.Report this figure(0.19)Basic EPS, Q3 FY2026, three months to 2026-02-28−$0.19 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-04-02, accession 0001628280-26-023008.Report this figurenot reported(0.17)Basic EPS, Q1 FY2027, three months to 2026-08-31−$0.17 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-10-08, accession 0001628280-26-065423.Report this figure

Balance sheet

Cash and equivalents$34.0m, Q1 FY2027
Long-term debt$0, FY2024
Shareholders' equity$164.0m, Q1 FY2027
Angiodynamics Inc, balance sheet, quarterly
Line itemUnitQ2 FY20242023-11-30Q3 FY20242024-02-29FY20242024-05-31Q1 FY20252024-08-31Q2 FY20252024-11-30Q3 FY20252025-02-28FY20252025-05-31Q1 FY20262025-08-31Q2 FY20262025-11-30Q3 FY20262026-02-28FY20262026-05-31Q1 FY20272026-08-31
Cash and equivalents$m60.9Cash and equivalents, Q2 FY2024, at 2023-11-30$60.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-01-08, accession 0001628280-24-000857.Report this figure78.5Cash and equivalents, Q3 FY2024, at 2024-02-29$78.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-04-09, accession 0001628280-24-015487.Report this figure76.1Cash and equivalents, FY2024, at 2024-05-31$76.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-07-18, accession 0001275187-25-000014.Report this figure55.0Cash and equivalents, Q1 FY2025, at 2024-08-31$55.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-10-03, accession 0001628280-24-042176.Report this figure54.1Cash and equivalents, Q2 FY2025, at 2024-11-30$54.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-01-08, accession 0001275187-25-000005.Report this figure44.8Cash and equivalents, Q3 FY2025, at 2025-02-28$44.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-04-02, accession 0001275187-25-000010.Report this figure55.9Cash and equivalents, FY2025, at 2025-05-31$55.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-07-14, accession 0001628280-26-048138.Report this figure38.8Cash and equivalents, Q1 FY2026, at 2025-08-31$38.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-10-02, accession 0001628280-25-043689.Report this figure41.6Cash and equivalents, Q2 FY2026, at 2025-11-30$41.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-01-06, accession 0001275187-26-000003.Report this figure37.8Cash and equivalents, Q3 FY2026, at 2026-02-28$37.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-04-02, accession 0001628280-26-023008.Report this figure53.9Cash and equivalents, FY2026, at 2026-05-31$53.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-10-08, accession 0001628280-26-065423.Report this figure34.0Cash and equivalents, Q1 FY2027, at 2026-08-31$34.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-10-08, accession 0001628280-26-065423.Report this figure
Current assets$m185Current assets, Q2 FY2024, at 2023-11-30$185.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-01-08, accession 0001628280-24-000857.Report this figure197Current assets, Q3 FY2024, at 2024-02-29$196.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-04-09, accession 0001628280-24-015487.Report this figure193Current assets, FY2024, at 2024-05-31$193.3m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-07-18, accession 0001275187-25-000014.Report this figure173Current assets, Q1 FY2025, at 2024-08-31$172.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-10-03, accession 0001628280-24-042176.Report this figure175Current assets, Q2 FY2025, at 2024-11-30$175.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-01-08, accession 0001275187-25-000005.Report this figure172Current assets, Q3 FY2025, at 2025-02-28$172.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-04-02, accession 0001275187-25-000010.Report this figure168Current assets, FY2025, at 2025-05-31$168.3m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-07-14, accession 0001628280-26-048138.Report this figure157Current assets, Q1 FY2026, at 2025-08-31$156.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-10-02, accession 0001628280-25-043689.Report this figure161Current assets, Q2 FY2026, at 2025-11-30$161.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-01-06, accession 0001275187-26-000003.Report this figure156Current assets, Q3 FY2026, at 2026-02-28$155.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-04-02, accession 0001628280-26-023008.Report this figure163Current assets, FY2026, at 2026-05-31$163.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-10-08, accession 0001628280-26-065423.Report this figure143Current assets, Q1 FY2027, at 2026-08-31$143.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-10-08, accession 0001628280-26-065423.Report this figure
Total assets$m500Total assets, Q2 FY2024, at 2023-11-30$499.6m. XBRL concept us-gaap:Assets. 10-Q filed 2024-01-08, accession 0001628280-24-000857.Report this figure325Total assets, Q3 FY2024, at 2024-02-29$324.8m. XBRL concept us-gaap:Assets. 10-Q filed 2024-04-09, accession 0001628280-24-015487.Report this figure318Total assets, FY2024, at 2024-05-31$317.7m. XBRL concept us-gaap:Assets. 10-K filed 2025-07-18, accession 0001275187-25-000014.Report this figure294Total assets, Q1 FY2025, at 2024-08-31$293.6m. XBRL concept us-gaap:Assets. 10-Q filed 2024-10-03, accession 0001628280-24-042176.Report this figure292Total assets, Q2 FY2025, at 2024-11-30$291.6m. XBRL concept us-gaap:Assets. 10-Q filed 2025-01-08, accession 0001275187-25-000005.Report this figure285Total assets, Q3 FY2025, at 2025-02-28$285.4m. XBRL concept us-gaap:Assets. 10-Q filed 2025-04-02, accession 0001275187-25-000010.Report this figure280Total assets, FY2025, at 2025-05-31$280.1m. XBRL concept us-gaap:Assets. 10-K filed 2026-07-14, accession 0001628280-26-048138.Report this figure266Total assets, Q1 FY2026, at 2025-08-31$265.6m. XBRL concept us-gaap:Assets. 10-Q filed 2025-10-02, accession 0001628280-25-043689.Report this figure270Total assets, Q2 FY2026, at 2025-11-30$269.7m. XBRL concept us-gaap:Assets. 10-Q filed 2026-01-06, accession 0001275187-26-000003.Report this figure261Total assets, Q3 FY2026, at 2026-02-28$260.7m. XBRL concept us-gaap:Assets. 10-Q filed 2026-04-02, accession 0001628280-26-023008.Report this figure267Total assets, FY2026, at 2026-05-31$267.2m. XBRL concept us-gaap:Assets. 10-Q filed 2026-10-08, accession 0001628280-26-065423.Report this figure242Total assets, Q1 FY2027, at 2026-08-31$241.9m. XBRL concept us-gaap:Assets. 10-Q filed 2026-10-08, accession 0001628280-26-065423.Report this figure
Current liabilities$m78.0Current liabilities, Q2 FY2024, at 2023-11-30$78.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-01-08, accession 0001628280-24-000857.Report this figure85.9Current liabilities, Q3 FY2024, at 2024-02-29$85.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-04-09, accession 0001628280-24-015487.Report this figure91.2Current liabilities, FY2024, at 2024-05-31$91.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-07-18, accession 0001275187-25-000014.Report this figure76.7Current liabilities, Q1 FY2025, at 2024-08-31$76.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-10-03, accession 0001628280-24-042176.Report this figure88.6Current liabilities, Q2 FY2025, at 2024-11-30$88.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-01-08, accession 0001275187-25-000005.Report this figure78.0Current liabilities, Q3 FY2025, at 2025-02-28$78.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-04-02, accession 0001275187-25-000010.Report this figure76.2Current liabilities, FY2025, at 2025-05-31$76.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-07-14, accession 0001628280-26-048138.Report this figure68.3Current liabilities, Q1 FY2026, at 2025-08-31$68.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-10-02, accession 0001628280-25-043689.Report this figure72.0Current liabilities, Q2 FY2026, at 2025-11-30$72.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-01-06, accession 0001275187-26-000003.Report this figure66.1Current liabilities, Q3 FY2026, at 2026-02-28$66.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-04-02, accession 0001628280-26-023008.Report this figure74.7Current liabilities, FY2026, at 2026-05-31$74.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-10-08, accession 0001628280-26-065423.Report this figure59.7Current liabilities, Q1 FY2027, at 2026-08-31$59.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-10-08, accession 0001628280-26-065423.Report this figure
Total liabilities$m98.4Total liabilities, Q2 FY2024, at 2023-11-30$98.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-01-08, accession 0001628280-24-000857.Report this figure106Total liabilities, Q3 FY2024, at 2024-02-29$106.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-04-09, accession 0001628280-24-015487.Report this figure112Total liabilities, FY2024, at 2024-05-31$112.1m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-07-18, accession 0001275187-25-000014.Report this figure97.0Total liabilities, Q1 FY2025, at 2024-08-31$97.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-10-03, accession 0001628280-24-042176.Report this figure105Total liabilities, Q2 FY2025, at 2024-11-30$104.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-01-08, accession 0001275187-25-000005.Report this figure99.5Total liabilities, Q3 FY2025, at 2025-02-28$99.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-04-02, accession 0001275187-25-000010.Report this figure97.2Total liabilities, FY2025, at 2025-05-31$97.2m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-07-14, accession 0001628280-26-048138.Report this figure86.8Total liabilities, Q1 FY2026, at 2025-08-31$86.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-10-02, accession 0001628280-25-043689.Report this figure93.3Total liabilities, Q2 FY2026, at 2025-11-30$93.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-01-06, accession 0001275187-26-000003.Report this figure87.3Total liabilities, Q3 FY2026, at 2026-02-28$87.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-04-02, accession 0001628280-26-023008.Report this figure96.3Total liabilities, FY2026, at 2026-05-31$96.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-10-08, accession 0001628280-26-065423.Report this figure78.0Total liabilities, Q1 FY2027, at 2026-08-31$78.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-10-08, accession 0001628280-26-065423.Report this figure
Long-term debt$mnot reportednot reported0.0Long-term debt, FY2024, at 2024-05-31$0. XBRL concept us-gaap:LongTermDebt. 10-K filed 2024-07-25, accession 0001628280-24-032989.Report this figurenot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Current portion of debt$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Shareholders' equity$m401Shareholders' equity, Q2 FY2024, at 2023-11-30$401.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-04-02, accession 0001275187-25-000010.Report this figure219Shareholders' equity, Q3 FY2024, at 2024-02-29$218.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-04-02, accession 0001275187-25-000010.Report this figure206Shareholders' equity, FY2024, at 2024-05-31$205.6m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-07-14, accession 0001628280-26-048138.Report this figure197Shareholders' equity, Q1 FY2025, at 2024-08-31$196.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-04-02, accession 0001628280-26-023008.Report this figure187Shareholders' equity, Q2 FY2025, at 2024-11-30$186.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-04-02, accession 0001628280-26-023008.Report this figure186Shareholders' equity, Q3 FY2025, at 2025-02-28$185.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-04-02, accession 0001628280-26-023008.Report this figure183Shareholders' equity, FY2025, at 2025-05-31$183.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-10-08, accession 0001628280-26-065423.Report this figure179Shareholders' equity, Q1 FY2026, at 2025-08-31$178.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-10-08, accession 0001628280-26-065423.Report this figure176Shareholders' equity, Q2 FY2026, at 2025-11-30$176.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-04-02, accession 0001628280-26-023008.Report this figure173Shareholders' equity, Q3 FY2026, at 2026-02-28$173.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-04-02, accession 0001628280-26-023008.Report this figure171Shareholders' equity, FY2026, at 2026-05-31$170.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-10-08, accession 0001628280-26-065423.Report this figure164Shareholders' equity, Q1 FY2027, at 2026-08-31$164.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-10-08, accession 0001628280-26-065423.Report this figure

Cash flow

Operating cash flow−$15.3m, Q1 FY2027
Capital expenditure$379.0k, Q1 FY2027
Share repurchases$0, Q4 FY2026
Angiodynamics Inc, cash flow, quarterly
Line itemUnitQ2 FY20242023-11-30Q3 FY20242024-02-29Q4 FY20242024-05-31Q1 FY20252024-08-31Q2 FY20252024-11-30Q3 FY20252025-02-28Q4 FY20252025-05-31Q1 FY20262025-08-31Q2 FY20262025-11-30Q3 FY20262026-02-28Q4 FY20262026-05-31Q1 FY20272026-08-31
Operating cash flow$m5.3Operating cash flow, Q2 FY2024, three months to 2023-11-30$5.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-01-08, accession 0001275187-25-000005. Derived: 6-month figure less the 3-month figure.Report this figure(12.5)Operating cash flow, Q3 FY2024, three months to 2024-02-29−$12.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-04-02, accession 0001275187-25-000010. Derived: 9-month figure less the 6-month figure.Report this figure5.0Operating cash flow, Q4 FY2024, three months to 2024-05-31$5.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-07-14, accession 0001628280-26-048138. Derived: 12-month figure less the 9-month figure.Report this figure(18.3)Operating cash flow, Q1 FY2025, three months to 2024-08-31−$18.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-10-02, accession 0001628280-25-043689.Report this figure2.5Operating cash flow, Q2 FY2025, three months to 2024-11-30$2.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-01-06, accession 0001275187-26-000003. Derived: 6-month figure less the 3-month figure.Report this figure(13.2)Operating cash flow, Q3 FY2025, three months to 2025-02-28−$13.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-04-02, accession 0001628280-26-023008. Derived: 9-month figure less the 6-month figure.Report this figure18.8Operating cash flow, Q4 FY2025, three months to 2025-05-31$18.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-07-14, accession 0001628280-26-048138. Derived: 12-month figure less the 9-month figure.Report this figure(15.9)Operating cash flow, Q1 FY2026, three months to 2025-08-31−$15.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-10-08, accession 0001628280-26-065423.Report this figure4.7Operating cash flow, Q2 FY2026, three months to 2025-11-30$4.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-01-06, accession 0001275187-26-000003. Derived: 6-month figure less the 3-month figure.Report this figure(3.1)Operating cash flow, Q3 FY2026, three months to 2026-02-28−$3.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-04-02, accession 0001628280-26-023008. Derived: 9-month figure less the 6-month figure.Report this figure17.5Operating cash flow, Q4 FY2026, three months to 2026-05-31$17.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-07-14, accession 0001628280-26-048138. Derived: 12-month figure less the 9-month figure.Report this figure(15.3)Operating cash flow, Q1 FY2027, three months to 2026-08-31−$15.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-10-08, accession 0001628280-26-065423.Report this figure
Capital expenditure$m0.6Capital expenditure, Q2 FY2024, three months to 2023-11-30$554.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-01-08, accession 0001275187-25-000005. Derived: 6-month figure less the 3-month figure.Report this figure0.6Capital expenditure, Q3 FY2024, three months to 2024-02-29$607.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-04-02, accession 0001275187-25-000010. Derived: 9-month figure less the 6-month figure.Report this figure0.6Capital expenditure, Q4 FY2024, three months to 2024-05-31$566.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-07-14, accession 0001628280-26-048138. Derived: 12-month figure less the 9-month figure.Report this figure1.1Capital expenditure, Q1 FY2025, three months to 2024-08-31$1.1m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-10-02, accession 0001628280-25-043689.Report this figure0.8Capital expenditure, Q2 FY2025, three months to 2024-11-30$797.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-01-06, accession 0001275187-26-000003. Derived: 6-month figure less the 3-month figure.Report this figure1.8Capital expenditure, Q3 FY2025, three months to 2025-02-28$1.8m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-04-02, accession 0001628280-26-023008. Derived: 9-month figure less the 6-month figure.Report this figure0.8Capital expenditure, Q4 FY2025, three months to 2025-05-31$777.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-07-14, accession 0001628280-26-048138. Derived: 12-month figure less the 9-month figure.Report this figure0.7Capital expenditure, Q1 FY2026, three months to 2025-08-31$731.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-10-08, accession 0001628280-26-065423.Report this figure0.4Capital expenditure, Q2 FY2026, three months to 2025-11-30$422.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-01-06, accession 0001275187-26-000003. Derived: 6-month figure less the 3-month figure.Report this figure1.0Capital expenditure, Q3 FY2026, three months to 2026-02-28$1.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-04-02, accession 0001628280-26-023008. Derived: 9-month figure less the 6-month figure.Report this figure0.4Capital expenditure, Q4 FY2026, three months to 2026-05-31$413.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-07-14, accession 0001628280-26-048138. Derived: 12-month figure less the 9-month figure.Report this figure0.4Capital expenditure, Q1 FY2027, three months to 2026-08-31$379.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-10-08, accession 0001628280-26-065423.Report this figure
Share repurchases$m0.0Share repurchases, Q2 FY2024, three months to 2023-11-30$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2025-01-08, accession 0001275187-25-000005. Derived: 6-month figure less the 3-month figure.Report this figure0.0Share repurchases, Q3 FY2024, three months to 2024-02-29$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2025-04-02, accession 0001275187-25-000010. Derived: 9-month figure less the 6-month figure.Report this figure0.0Share repurchases, Q4 FY2024, three months to 2024-05-31$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-K filed 2026-07-14, accession 0001628280-26-048138. Derived: 12-month figure less the 9-month figure.Report this figure0.6Share repurchases, Q1 FY2025, three months to 2024-08-31$552.0k. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2025-10-02, accession 0001628280-25-043689.Report this figure1.1Share repurchases, Q2 FY2025, three months to 2024-11-30$1.1m. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2026-01-06, accession 0001275187-26-000003. Derived: 6-month figure less the 3-month figure.Report this figure0.0Share repurchases, Q3 FY2025, three months to 2025-02-28$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2026-04-02, accession 0001628280-26-023008. Derived: 9-month figure less the 6-month figure.Report this figure0.0Share repurchases, Q4 FY2025, three months to 2025-05-31$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-K filed 2026-07-14, accession 0001628280-26-048138. Derived: 12-month figure less the 9-month figure.Report this figure0.0Share repurchases, Q1 FY2026, three months to 2025-08-31$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2025-10-02, accession 0001628280-25-043689.Report this figure0.0Share repurchases, Q2 FY2026, three months to 2025-11-30$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2026-01-06, accession 0001275187-26-000003. Derived: 6-month figure less the 3-month figure.Report this figure0.0Share repurchases, Q3 FY2026, three months to 2026-02-28$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2026-04-02, accession 0001628280-26-023008. Derived: 9-month figure less the 6-month figure.Report this figure0.0Share repurchases, Q4 FY2026, three months to 2026-05-31$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-K filed 2026-07-14, accession 0001628280-26-048138. Derived: 12-month figure less the 9-month figure.Report this figurenot reported

Shares

Diluted shares (weighted)42.02m, Q1 FY2027
Angiodynamics Inc, shares, quarterly
Line itemUnitQ2 FY20232022-11-30Q3 FY20232023-02-28Q1 FY20242023-08-31Q2 FY20242023-11-30Q3 FY20242024-02-29Q1 FY20252024-08-31Q2 FY20252024-11-30Q3 FY20252025-02-28Q1 FY20262025-08-31Q2 FY20262025-11-30Q3 FY20262026-02-28Q1 FY20272026-08-31
Diluted shares (weighted)m shares39.5Diluted shares (weighted), Q2 FY2023, three months to 2022-11-3039,490,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-01-08, accession 0001628280-24-000857.Report this figure39.5Diluted shares (weighted), Q3 FY2023, three months to 2023-02-2839,509,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-04-09, accession 0001628280-24-015487.Report this figure40.0Diluted shares (weighted), Q1 FY2024, three months to 2023-08-3139,968,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-10-03, accession 0001628280-24-042176.Report this figure40.2Diluted shares (weighted), Q2 FY2024, three months to 2023-11-3040,219,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-01-08, accession 0001275187-25-000005.Report this figure40.2Diluted shares (weighted), Q3 FY2024, three months to 2024-02-2940,234,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-04-02, accession 0001275187-25-000010.Report this figure40.7Diluted shares (weighted), Q1 FY2025, three months to 2024-08-3140,653,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-10-02, accession 0001628280-25-043689.Report this figure40.9Diluted shares (weighted), Q2 FY2025, three months to 2024-11-3040,922,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-01-06, accession 0001275187-26-000003.Report this figure40.9Diluted shares (weighted), Q3 FY2025, three months to 2025-02-2840,853,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-04-02, accession 0001628280-26-023008.Report this figure41.2Diluted shares (weighted), Q1 FY2026, three months to 2025-08-3141,174,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-10-08, accession 0001628280-26-065423.Report this figure41.5Diluted shares (weighted), Q2 FY2026, three months to 2025-11-3041,542,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-01-06, accession 0001275187-26-000003.Report this figure41.6Diluted shares (weighted), Q3 FY2026, three months to 2026-02-2841,596,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-04-02, accession 0001628280-26-023008.Report this figure42.0Diluted shares (weighted), Q1 FY2027, three months to 2026-08-3142,022,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-10-08, accession 0001628280-26-065423.Report this figure

Shares outstanding: 42.05mShares outstanding, period not labelled, at 2026-10-0742,054,450 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-10-08, accession 0001628280-26-065423.Report this figure at Oct 7, 2026, from the cover of the 10-Q filed Oct 8, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:35 ET. Listed shows no prices and gives no investment advice.